Cell cycle arrest biomarkers, including tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7), have shown potential for early AKI detection in critically ill human patients; however, evidence in veterinary medicine remains limited. Here, TIMP2 is linked to acute kidney injury.